Important Safety Information | Prescribing Information







Help your eligible patients save on LOTEMAX GEL



Continued commitment to help you treat your patients


LOTEMAX GEL has ~80% unrestricted
managed care access on commercial insurance plans*

*Fingertip Formulary data 2017


PATIENT SAVINGS

 

Eligible Commercially Insured Patients | Pay No More Than $25 Co-Pay


Special Savings Offer: Most eligible commercially insured patients PAY NO MORE THAN $25 co-pay for 1st prescription and eligible refills. Discounted pricing is also available for eligible uninsured patients.

To help eligible patients save, visit the link below to access web coupons or contact your sales representative to provide printed coupons in-office.







ENSURE YOUR PATIENTS ACTIVATE THEIR COUPON

ACTIVATE: To activate the print coupon, call 1-855-280-0580.
To activate the online Web coupon, visit www.bauschaccessprogram.com and follow the instructions.

Bausch + Lomb has aligned with Walgreens to stock product and help eligible patients redeem special
prescription savings on LOTEMAX GEL.


If you have any questions regarding the program, please call 1-855-280-0580.

Terms and conditions apply. Please see www.bauschaccessprogram.com and www.lotemaxgelpartdcoupon.com
for eligibility criteria and terms and conditions.

 

Medicare Part D Patients | Pay No More Than $60 Co-Pay


Medicare Part D Insured Patients
Most eligible patients PAY NO MORE THAN $60 on each LOTEMAX GEL prescription.

ENSURE YOUR eligible PATIENT ACTIVATES THEIR COUPON

  1. ACTIVATE: To activate the print coupon, call 1-800-670-4615. Web coupon is automatically activated once patient agrees to statements on www.lotemaxgelpartdcoupon.com to download coupon.

  2. REDEEM: Redeem the coupon card at a participating retail pharmacy with prescription and insurance card.

  3. MAIL: Sign and mail the prewritten letter to health plan. Health care plan address can be found on the Medicare provider card.



To help patients save, visit the link below to access
web coupons or contact your sales representative to provide printed coupons in-office.





If you have questions related to this program,
please call 1-800-670-4615.







Terms and conditions apply. Please see www.bauschaccessprogram.com and www.lotemaxgelpartdcoupon.com
  for eligibility criteria and terms and conditions.

 





Indication

LOTEMAX GEL (loteprednol etabonate ophthalmic gel) 0.5% is indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Important Safety Information

  • LOTEMAX GEL is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.
  • Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. If this product is used for 10 days or longer, IOP should be monitored.
  • Use of corticosteroids may result in posterior subcapsular cataract formation.
  • Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation and occurrence of perforations in those with diseases causing corneal and scleral thinning. The initial prescription and renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification, and where appropriate, fluorescein staining.
  • Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infection. In acute purulent conditions, steroids may mask infection or enhance existing infections.
  • Use of corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and exacerbate the severity of many viral infections of the eye (including herpes simplex).
  • Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use.
  • Patients should not wear contact lenses when using LOTEMAX GEL.
  • The most common ocular adverse drug reactions were anterior chamber inflammation (5%), eye pain (2%) and foreign body sensation (2%).

Please click here for full Prescribing Information about LOTEMAX GEL.

LGX.0072.USA.17